Share on StockTwits

Gevo (NASDAQ:GEVO) COO Christopher Michael Ryan unloaded 2,248 shares of the company’s stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $0.81, for a total value of $1,820.88. Following the transaction, the chief operating officer now directly owns 368,568 shares in the company, valued at approximately $298,540. The sale was disclosed in a filing with the SEC, which is available at this link.

A number of analysts have recently weighed in on GEVO shares. Analysts at Cowen and Company cut their price target on shares of Gevo to $1.00 in a research note on Friday, May 16th. Analysts at Zacks downgraded shares of Gevo from an “outperform” rating to a “neutral” rating in a research note on Thursday, May 8th. They now have a $1.30 price target on the stock.

Gevo (NASDAQ:GEVO) traded down 3.83% during mid-day trading on Wednesday, hitting $0.7714. The stock had a trading volume of 218,742 shares. Gevo has a 52-week low of $0.73 and a 52-week high of $2.18. The stock has a 50-day moving average of $0.88 and a 200-day moving average of $1.12. The company’s market cap is $52.3 million.

Gevo (NASDAQ:GEVO) last announced its earnings results on Wednesday, May 14th. The company reported ($0.18) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.21) by $0.03. The company had revenue of $0.90 million for the quarter, compared to the consensus estimate of $1.70 million. During the same quarter last year, the company posted ($0.45) earnings per share. Gevo’s revenue was down 74.3% compared to the same quarter last year. On average, analysts predict that Gevo will post $-0.67 earnings per share for the current fiscal year.

Gevo, Inc, is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.